Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_assertion type Assertion NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_head.
- NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_assertion description "[Previous semiquantitative studies of patients with chronic viral hepatitis showed that liver TGF beta 1 messenger RNA (mRNA) was increased, compared with normal controls and with patients with chronic hepatitis C virus (HCV) infection who responded favorably to interferon alfa (IFN alpha) treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.
- NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_assertion evidence source_evidence_literature NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.
- NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_assertion SIO_000772 7843697 NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.
- NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_assertion wasDerivedFrom befree-2016 NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.
- NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_assertion wasGeneratedBy ECO_0000203 NP1323588.RAi7rrGYs4C-yBJPe3GOMv4r31fdPxlo8uUAcvM2XLaTg130_provenance.